Is it Time to Move Beyond STS and TVT Scores for Predicting TAVR Mortality?
作者信息
Goel Sachin S, Reardon Michael J
机构信息
Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas.
Department of Cardiovascular Surgery, Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas.
出版信息
J Soc Cardiovasc Angiogr Interv. 2023 Apr 21;2(3):100633. doi: 10.1016/j.jscai.2023.100633. eCollection 2023 May-Jun.
Abstract
摘要
相似文献
1
Is it Time to Move Beyond STS and TVT Scores for Predicting TAVR Mortality?是否到了超越STS和TVT评分来预测经导管主动脉瓣置换术死亡率的时候了？
J Soc Cardiovasc Angiogr Interv. 2023 Apr 21;2(3):100633. doi: 10.1016/j.jscai.2023.100633. eCollection 2023 May-Jun.
2
Validation of STS/ACC TVT-TAVR Score in Veterans Undergoing Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术退伍军人中STS/ACC TVT-TAVR评分的验证
J Invasive Cardiol. 2018 Dec;30(12):447-451. Epub 2018 Sep 15.
3
Assessment of TVT and STS Risk Score Performances in Patients Undergoing Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术患者中TVT和STS风险评分表现的评估
J Soc Cardiovasc Angiogr Interv. 2023 Apr 21;2(3):100600. doi: 10.1016/j.jscai.2023.100600. eCollection 2023 May-Jun.
4
Annual Outcomes With Transcatheter Valve Therapy: From the STS/ACC TVT Registry.经导管瓣膜治疗的年度结果：来自 STS/ACC TVT 注册研究。
J Am Coll Cardiol. 2015 Dec 29;66(25):2813-2823. doi: 10.1016/j.jacc.2015.10.021. Epub 2015 Nov 30.
5
Outcomes Following Urgent/Emergent Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT Registry.紧急/即刻经导管主动脉瓣置换术后的结局：STS/ACC TVT 注册研究的见解。
JACC Cardiovasc Interv. 2018 Jun 25;11(12):1175-1185. doi: 10.1016/j.jcin.2018.03.002. Epub 2018 Mar 11.
6
Outcomes of Prosthesis-Patient Mismatch Following Supra-Annular Transcatheter Aortic Valve Replacement: From the STS/ACC TVT Registry.经导管主动脉瓣环上置换术后人工瓣膜-患者不匹配的结局：来自美国胸外科医师协会/美国心脏病学会经导管瓣膜治疗注册研究
JACC Cardiovasc Interv. 2021 May 10;14(9):964-976. doi: 10.1016/j.jcin.2021.03.040.
7
Outcomes for the Commercial Use of Self-Expanding Prostheses in Transcatheter Aortic Valve Replacement: A Report From the STS/ACC TVT Registry.经导管主动脉瓣置换术中自膨式假体的商业应用结局：来自 STS/ACC TVT 注册研究的报告。
JACC Cardiovasc Interv. 2017 Oct 23;10(20):2090-2098. doi: 10.1016/j.jcin.2017.07.027.
8
Association of Patient-Reported Health Status With Long-Term Mortality After Transcatheter Aortic Valve Replacement: Report From the STS/ACC TVT Registry.经导管主动脉瓣置换术后患者报告的健康状况与长期死亡率的关联：来自美国胸外科医师协会/美国心脏病学会经导管瓣膜治疗注册研究的报告
Circ Cardiovasc Interv. 2015 Dec;8(12):e002875. doi: 10.1161/CIRCINTERVENTIONS.115.002875.
9
The Society of Thoracic Surgery Risk Score as a Predictor of 30-Day Mortality in Transcatheter vs Surgical Aortic Valve Replacement: A Single-Center Experience and its Implications for the Development of a TAVR Risk-Prediction Model.胸外科医师协会风险评分作为经导管与外科主动脉瓣置换术30天死亡率的预测指标：单中心经验及其对经导管主动脉瓣置换术风险预测模型开发的启示
J Invasive Cardiol. 2017 Mar;29(3):109-114.
10
Mortality prediction following transcatheter aortic valve replacement: A quantitative comparison of risk scores derived from populations treated with either surgical or percutaneous aortic valve replacement. The Israeli TAVR Registry Risk Model Accuracy Assessment (IRRMA) study.经导管主动脉瓣置换术后的死亡率预测：对接受外科或经皮主动脉瓣置换术治疗人群得出的风险评分进行定量比较。以色列经导管主动脉瓣置换术注册风险模型准确性评估（IRRMA）研究。
Int J Cardiol. 2016 Jul 15;215:227-31. doi: 10.1016/j.ijcard.2016.04.038. Epub 2016 Apr 25.
本文引用的文献
1
Evolution and Prognostic Impact of Cardiac Damage After Aortic Valve Replacement.主动脉瓣置换术后心脏损伤的演变及其预后影响。
J Am Coll Cardiol. 2022 Aug 23;80(8):783-800. doi: 10.1016/j.jacc.2022.05.006. Epub 2022 May 17.
2
Trends in Transcatheter and Surgical Aortic Valve Replacement Among Older Adults in the United States.美国老年患者经导管主动脉瓣置换术与外科主动脉瓣置换术的发展趋势。
J Am Coll Cardiol. 2021 Nov 30;78(22):2161-2172. doi: 10.1016/j.jacc.2021.09.855.
3
Predicting and measuring mortality risk after transcatheter aortic valve replacement.经导管主动脉瓣置换术后死亡率的预测和评估。
Expert Rev Cardiovasc Ther. 2021 Mar;19(3):247-260. doi: 10.1080/14779072.2021.1888715. Epub 2021 Mar 2.
4
Inclusion of Functional Status Measures in the Risk Adjustment of 30-Day Mortality After Transcatheter Aortic Valve Replacement: A Report From the Society of Thoracic Surgeons/American College of Cardiology TVT Registry.在经导管主动脉瓣置换术后 30 天死亡率的风险调整中纳入功能状态测量：来自胸外科医师学会/美国心脏病学会经导管主动脉瓣置换术登记处的报告。
JACC Cardiovasc Interv. 2018 Mar 26;11(6):581-589. doi: 10.1016/j.jcin.2018.01.242.
5
Performance of contemporary surgical risk scores for transcatheter aortic valve implantation: A meta-analysis.当代经导管主动脉瓣植入手术风险评分的性能：一项荟萃分析。
Int J Cardiol. 2017 Jun 1;236:350-355. doi: 10.1016/j.ijcard.2016.12.188. Epub 2017 Jan 16.
6
Development and Validation of a Risk Prediction Model for In-Hospital Mortality After Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术后住院死亡率风险预测模型的建立与验证。
JAMA Cardiol. 2016 Apr 1;1(1):46-52. doi: 10.1001/jamacardio.2015.0326.
Zotero 插件